Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation

    NEXT STORY
    Oncology Venture reaches new development milestone with Dovitinib.
    PREV STORY
    Oncology Venture is streamlining its communications by publishing press releases in English only going forward.
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Crohn’s and Colitis Canada Celebrates the 10th Anniversary of the AbbVie IBD Scholarship Program

    author_avatar
    NASDAQ Market News

    Affimed Reports Second Quarter 2019 Financial and Operational Results

    author_avatar
    NASDAQ Market News

    GBT is Developing an AI Based Graphics Analytics System

    author_avatar
    NASDAQ Market News